Johnson & Johnson's Janssen on Friday earned an FDA approval for its cancer drug Rybrevant (amivantamab-vmjw) for the ...
At its meeting in Atlanta this week, the CDC’s Advisory Committee on Immunization Practices recommended Covid-19 boosters for ...
HHS’ newest biomedical research arm has yet to finalize its charter for its advisory committee or explain how members will ...
Cardiff Oncology’s PLK1 inhibitor showed hints of efficacy in a shelved Phase II test in second-line colorectal cancer, ...
The FDA is aiming to make it easier for clinical trial participants to understand informed consent, offering trial sponsors ...
The Biden administration is doling out $48 million to a nonprofit that wants to use machine learning and artificial ...
Moderna said in June that it was “quadrupling down” on rare disease. Right now, that looks like nine or so INDs in the ...
Arrakis Therapeutics has prioritized its pipeline and reduced its headcount by about 20% this week, the biotech's CEO said in ...
Eli Lilly bought an old, ivy-covered brick house in Marktbreit, Germany. The house was the childhood home of Alois Alzheimer, ...
Sarepta Therapeutics announced Wednesday afternoon that its Duchenne muscular dystrophy gene therapy Elevidys pulled in $200 ...
As weight loss drugs boom in popularity, employers want more personalized approaches that go beyond solely prescribing the ...
KIT antibody hit the primary endpoint in a mid-stage test in chronic spontaneous urticaria, with some analysts describing the ...